A prospective randomized trial comparing the clinical effectiveness and biocompatibility of heparin-coated circuits and PMEA-coated circuits in pediatric cardiopulmonary bypass

Hideshi Itoh, Shingo Ichiba, Yoshihito Ujike, Takuma Douguchi, Shingo Kasahara, Sadahiko Arai, Shunji Sano

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Object: We compared the clinical effectiveness and biocompatibility of poly-2-methoxyethyl acrylate (PMEA)-coated and heparin-coated cardiopulmonary bypass (CPB) circuits in a prospective pediatric trial. Methods: Infants randomly received heparin-coated (n=7) or PMEA-coated (n=7) circuits in elective pediatric cardiac surgery with CPB for ventricular septum defects. Clinical and hematologic variables, respiratory indices and hemodynamic changes were analyzed perioperatively. Results: Demographic and clinical variables were similar in both groups. Leukocyte counts were significantly lower 5 minutes after CPB in the PMEA group than the heparin group. Hemodynamic data showed that PMEA caused hypotension within 5 minutes of CPB. The respiratory index was significantly higher immediately after CPB and 1 hour after transfer to the intensive care unit (ICU) in the PMEA group, as were levels of C-reactive protein 24 hours after transfer to the ICU. Conclusion: Our study shows that PMEA-coated circuits, unlike heparin-coated circuits, cause transient leukopenia during pediatric CPB and, perhaps, systemic inflammatory respiratory syndrome after pediatric CPB.

Original languageEnglish
Pages (from-to)247-254
Number of pages8
JournalPerfusion
Volume31
Issue number3
DOIs
Publication statusPublished - Apr 1 2016

Fingerprint

Pediatrics
Cardiopulmonary Bypass
Biocompatibility
Heparin
Intensive care units
Networks (circuits)
Hemodynamics
Group
Intensive Care Units
Surgery
surgery
infant
Ventricular Septum
Proteins
Leukopenia
Defects
cause
acrylic acid
Leukocyte Count
C-Reactive Protein

Keywords

  • cardiopulmonary bypass
  • heparin coating
  • pediatric
  • PMEA coating
  • transient leukopenia

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging
  • Advanced and Specialised Nursing
  • Safety Research

Cite this

A prospective randomized trial comparing the clinical effectiveness and biocompatibility of heparin-coated circuits and PMEA-coated circuits in pediatric cardiopulmonary bypass. / Itoh, Hideshi; Ichiba, Shingo; Ujike, Yoshihito; Douguchi, Takuma; Kasahara, Shingo; Arai, Sadahiko; Sano, Shunji.

In: Perfusion, Vol. 31, No. 3, 01.04.2016, p. 247-254.

Research output: Contribution to journalArticle

Itoh, Hideshi ; Ichiba, Shingo ; Ujike, Yoshihito ; Douguchi, Takuma ; Kasahara, Shingo ; Arai, Sadahiko ; Sano, Shunji. / A prospective randomized trial comparing the clinical effectiveness and biocompatibility of heparin-coated circuits and PMEA-coated circuits in pediatric cardiopulmonary bypass. In: Perfusion. 2016 ; Vol. 31, No. 3. pp. 247-254.
@article{d46cef78284e41338ea82e8abe851cf8,
title = "A prospective randomized trial comparing the clinical effectiveness and biocompatibility of heparin-coated circuits and PMEA-coated circuits in pediatric cardiopulmonary bypass",
abstract = "Object: We compared the clinical effectiveness and biocompatibility of poly-2-methoxyethyl acrylate (PMEA)-coated and heparin-coated cardiopulmonary bypass (CPB) circuits in a prospective pediatric trial. Methods: Infants randomly received heparin-coated (n=7) or PMEA-coated (n=7) circuits in elective pediatric cardiac surgery with CPB for ventricular septum defects. Clinical and hematologic variables, respiratory indices and hemodynamic changes were analyzed perioperatively. Results: Demographic and clinical variables were similar in both groups. Leukocyte counts were significantly lower 5 minutes after CPB in the PMEA group than the heparin group. Hemodynamic data showed that PMEA caused hypotension within 5 minutes of CPB. The respiratory index was significantly higher immediately after CPB and 1 hour after transfer to the intensive care unit (ICU) in the PMEA group, as were levels of C-reactive protein 24 hours after transfer to the ICU. Conclusion: Our study shows that PMEA-coated circuits, unlike heparin-coated circuits, cause transient leukopenia during pediatric CPB and, perhaps, systemic inflammatory respiratory syndrome after pediatric CPB.",
keywords = "cardiopulmonary bypass, heparin coating, pediatric, PMEA coating, transient leukopenia",
author = "Hideshi Itoh and Shingo Ichiba and Yoshihito Ujike and Takuma Douguchi and Shingo Kasahara and Sadahiko Arai and Shunji Sano",
year = "2016",
month = "4",
day = "1",
doi = "10.1177/0267659115598217",
language = "English",
volume = "31",
pages = "247--254",
journal = "Perfusion (United Kingdom)",
issn = "0267-6591",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - A prospective randomized trial comparing the clinical effectiveness and biocompatibility of heparin-coated circuits and PMEA-coated circuits in pediatric cardiopulmonary bypass

AU - Itoh, Hideshi

AU - Ichiba, Shingo

AU - Ujike, Yoshihito

AU - Douguchi, Takuma

AU - Kasahara, Shingo

AU - Arai, Sadahiko

AU - Sano, Shunji

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Object: We compared the clinical effectiveness and biocompatibility of poly-2-methoxyethyl acrylate (PMEA)-coated and heparin-coated cardiopulmonary bypass (CPB) circuits in a prospective pediatric trial. Methods: Infants randomly received heparin-coated (n=7) or PMEA-coated (n=7) circuits in elective pediatric cardiac surgery with CPB for ventricular septum defects. Clinical and hematologic variables, respiratory indices and hemodynamic changes were analyzed perioperatively. Results: Demographic and clinical variables were similar in both groups. Leukocyte counts were significantly lower 5 minutes after CPB in the PMEA group than the heparin group. Hemodynamic data showed that PMEA caused hypotension within 5 minutes of CPB. The respiratory index was significantly higher immediately after CPB and 1 hour after transfer to the intensive care unit (ICU) in the PMEA group, as were levels of C-reactive protein 24 hours after transfer to the ICU. Conclusion: Our study shows that PMEA-coated circuits, unlike heparin-coated circuits, cause transient leukopenia during pediatric CPB and, perhaps, systemic inflammatory respiratory syndrome after pediatric CPB.

AB - Object: We compared the clinical effectiveness and biocompatibility of poly-2-methoxyethyl acrylate (PMEA)-coated and heparin-coated cardiopulmonary bypass (CPB) circuits in a prospective pediatric trial. Methods: Infants randomly received heparin-coated (n=7) or PMEA-coated (n=7) circuits in elective pediatric cardiac surgery with CPB for ventricular septum defects. Clinical and hematologic variables, respiratory indices and hemodynamic changes were analyzed perioperatively. Results: Demographic and clinical variables were similar in both groups. Leukocyte counts were significantly lower 5 minutes after CPB in the PMEA group than the heparin group. Hemodynamic data showed that PMEA caused hypotension within 5 minutes of CPB. The respiratory index was significantly higher immediately after CPB and 1 hour after transfer to the intensive care unit (ICU) in the PMEA group, as were levels of C-reactive protein 24 hours after transfer to the ICU. Conclusion: Our study shows that PMEA-coated circuits, unlike heparin-coated circuits, cause transient leukopenia during pediatric CPB and, perhaps, systemic inflammatory respiratory syndrome after pediatric CPB.

KW - cardiopulmonary bypass

KW - heparin coating

KW - pediatric

KW - PMEA coating

KW - transient leukopenia

UR - http://www.scopus.com/inward/record.url?scp=84960803700&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960803700&partnerID=8YFLogxK

U2 - 10.1177/0267659115598217

DO - 10.1177/0267659115598217

M3 - Article

C2 - 26228276

AN - SCOPUS:84960803700

VL - 31

SP - 247

EP - 254

JO - Perfusion (United Kingdom)

JF - Perfusion (United Kingdom)

SN - 0267-6591

IS - 3

ER -